Do you want to read an article? Please log in or register.
Real-World Efficacy of BDP/FF/G Fixed Triple Inhalation Powder (NEXThaler) Therapy in the Treatment of Moderate to Severe COPD patients (RESPONSE Study)
COPD
RECOMMENDED
Related content
RECOMMENDED
Asthma
Efficacy and safety of novel fixed dose combination of vilanterol, glycopyrronium, and fluticasone furoate dry powder inhaler: A phase 3, randomized, non-inferiority trial compared with fixed dose combination of indacaterol, glycopyrronium, and mometasone furoate dry powder inhaler in Indian asthma patients
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Patel C, Sheth V, Koppula R, Kumar A, Bhate AS, Sahoo D, Jain MK, Mondal A, Parmar D, Kansagra K, Shrivastava R, Pathak H
doi: 10.1016/j.rmed.2025.108293
Asthma
Real-World Effectiveness of Fluticasone Furoate/Umeclidinium/Vilanterol Initiation in Japanese Patients with Asthma Previously on Inhaled Corticosteroid/Long-Acting β(2)-Agonist Therapy: A Retrospective Cohort Study
J Clin Med
Oga T, Gon Y, Takano M, Ito R, Mita C, Mukai I, Noorduyn SG, Requena G, Yarita M
doi: 10.3390/jcm14082566
Asthma
Effectiveness of Mepolizumab in Patients with OCS-Dependent Severe Asthma: A Real-World Study
Adv Ther
Bavbek S, Al-Ahmad M, Samaha H, Kathuria PC, Fernandez P, Al Busaidi N, Ibrahim T, Mahboub B, Haider S, Noibi S, Levy G, Al-Lehebi RO
doi: 10.1007/s12325-025-03338-w
COPD
Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β(2)-agonist: post-hoc analyses of KRONOS
Respir Res
Singh D, Bafadhel M, Arya N, Marshall J, Parikh H, Kisielewicz D, Movitz C, Bowen K, Patel M
doi: 10.1186/s12931-025-03234-5
Asthma
Real-world use of beclometasone dipropionate and formoterol fumarate NEXThaler® and asthma control among adult asthmatic patients in Europe: The results of the NEWTON Study
Respir Med
Braido F, Beeh KM, Serrano CC, Dinh-Xuan AT, Tamási L, Trofor A, Ingrassia E, Piraino A, Caruso C, NEWTON study group
doi: 10.1016/j.rmed.2025.108224
RECOMMENDED
COPDLung Cancer
Impact of Triple Inhaler Therapy on COPD Patients with Non-Small Cell Lung Cancer After Radical Surgery: A Single-Centre Retrospective Analysis
★ 1
Recommended by
Dr Martin Frey, Faculty Member
J Clin Med
Bertuccio FR, D'Agnano V, Cordoni S, Tafa M, Novy C, Baio N, Mucaj K, Bortolotto C, Melloni G, Bianco A, Corsico AG, Perrotta F, Stella GM
doi: 10.3390/jcm14010249
Lung Cancer
Real-World Treatment Patterns and Clinical Outcomes in Patients With Extensive-Stage Small Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy and ≥ 2 Subsequent Lines of Therapy in the United States
Adv Ther
Sankar K, Unni S, Eberl M, Le H, Herrmann T, Gorsh B, Tang M, Coerts F, Ahmed S
doi: 10.1007/s12325-025-03408-z
RECOMMENDED
Asthma
Early and Sustained Response to Benralizumab in Severe, Eosinophilic Asthma: A Real-World Observational Study
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
J Asthma Allergy
Stolz D, Schuoler C, Charbonnier F, Bridevaux PO, Jandus P, Leuppi JD, Pavlov N, Piecyk A, Rothe T
doi: 10.2147/JAA.S495867
COPD
Comparison of the Risk of Pneumonia Between Fluticasone Furoate/Umeclidinium/Vilanterol and Multiple-Inhaler Triple Therapy in Patients with COPD Using Health Insurance Claims Data: Final Analysis of Post-Marketing Database Surveillance in Japan
J Clin Med
Akiyama S, Oda K, Mizohata H, Sasakura N, Hashimoto K, Maruoka H
doi: 10.3390/jcm14134697